Thursday, April 16, 2020, 8:00 AM - 4:00 PM, SRI, 301 Ravenswood Ave, Menlo Park, CA

All Specialties, Oncology

The learner will gain knowledge in new strategies for cancer treatment including immunotherapy and targeted therapies, management of toxicities related to treatment (radiation and chemotherapy/immunotherapy) survivorship care, skin toxicity, new interventional approaches to care treatment, assessment and social toxicities in the cancer patient, ASCO updates, and mindfulness based stress reduction for providers. By the end of this course, learners will be able to apply their knowledge to their practice when managing short and long-term side effects of cancer and cancer treatments in patients they care for.

1. Identify new innovative options for cancer therapy.
2. Discuss common treatment related toxicities and strategies for management.
3. Describe strategies for caring for patients at the end of life

Stanford Health Care is provider approved by the California Board of Registered Nursing (BRN). BRN Provider Number CEP12165.

Stanford Health Care Center for Education and Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

 Neither SHC nor ANCC endorse any commercial products.

This program is not yet approved for CME credit. Conference organizers plan to request 6.5 AAPA Category 1 CME credits from the Physician Assistant Review Panel. Total number of approved credits yet to be determined.

2020 by Stanford Health Care, Division of Patient Care Services.
All rights reserved. No audio or video taping allowed. We reserve the right to make program changes. All students must be registered, attend the entire course, and submit an evaluation after course completion to earn credit hours.

Thursday, April 16, 2020

---

Keywords: